Association of myeloperoxidase with heparin: oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme
- PMID: 9655178
- DOI: 10.1023/a:1006848730927
Association of myeloperoxidase with heparin: oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme
Abstract
Chromatography of human myeloperoxidase (MPO) on a heparin-agarose column demonstrated a tight association of the protein with the resin. The electrophoretic mobility of mixtures of MPO and heparin in polyacrylamide gels under nondenaturing conditions was consistent with a strong interaction of the cationic enzyme with the polyanionic polysaccharide. Purified MPO prebound to bovine aorta endothelial cells (BAEC) and supplemented with hydrogen peroxide dose- and time-dependently abrogated the interaction of coagulation factor IX (FIX) with factor IX-binding protein (FIXBP) on the surface of BAEC reflecting oxidative modification of the binding protein. This inactivation of FIXBP required the presence of chloride implicating hypochlorite in the reaction. Hypochlorite and activated neutrophils exerted a similar effect. The oxidative modification of FIXBP was only partially dependent on the addition of hydrogen peroxide and was abolished by exogenous heparin which displaced MPO from the cell surface, emphasizing the functional differences between cell-bound and free enzyme.
Similar articles
-
Myeloperoxidase amplified high glucose-induced endothelial dysfunction in vasculature: Role of NADPH oxidase and hypochlorous acid.Biochem Biophys Res Commun. 2017 Mar 11;484(3):572-578. doi: 10.1016/j.bbrc.2017.01.132. Epub 2017 Jan 26. Biochem Biophys Res Commun. 2017. PMID: 28131839
-
Transfer of specific endothelial cell-binding properties from the procoagulant protein human factor IX into the anticoagulant protein human protein C.Biochemistry. 1995 Jul 4;34(26):8449-57. doi: 10.1021/bi00026a028. Biochemistry. 1995. PMID: 7541242
-
Myeloperoxidase and hypochlorite, but not copper ions, oxidize heparin-bound LDL particles and release them from heparin.Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1902-8. doi: 10.1161/hq1201.099423. Arterioscler Thromb Vasc Biol. 2001. PMID: 11742862
-
Myeloperoxidase in kidney disease.Kidney Int. 2003 Dec;64(6):1956-67. doi: 10.1046/j.1523-1755.2003.00336.x. Kidney Int. 2003. PMID: 14633118 Review.
-
Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids.Free Radic Res. 2012 Aug;46(8):975-95. doi: 10.3109/10715762.2012.667566. Epub 2012 Apr 23. Free Radic Res. 2012. PMID: 22348603 Review.
Cited by
-
Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration.J Clin Invest. 2001 Dec;108(12):1759-70. doi: 10.1172/JCI12617. J Clin Invest. 2001. PMID: 11748259 Free PMC article.
-
Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention.J Clin Biochem Nutr. 2011 Jan;48(1):8-19. doi: 10.3164/jcbn.11-006FR. Epub 2010 Dec 28. J Clin Biochem Nutr. 2011. PMID: 21297906 Free PMC article.
-
The Dual Role of Myeloperoxidase in Immune Response.Int J Mol Sci. 2020 Oct 29;21(21):8057. doi: 10.3390/ijms21218057. Int J Mol Sci. 2020. PMID: 33137905 Free PMC article. Review.
-
Bivalirudin decreases NO bioavailability by vascular immobilization of myeloperoxidase.J Pharmacol Exp Ther. 2008 Nov;327(2):324-31. doi: 10.1124/jpet.108.142414. Epub 2008 Aug 13. J Pharmacol Exp Ther. 2008. PMID: 18701766 Free PMC article. Clinical Trial.
-
Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques.Biochem J. 2003 Mar 1;370(Pt 2):729-35. doi: 10.1042/BJ20021710. Biochem J. 2003. PMID: 12456264 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous